Forte Biosciences, Inc. (FBRX)
23.63
-3.64
(-13.35%)
USD |
NASDAQ |
Jan 02, 16:00
24.07
+0.44
(+1.86%)
After-Hours: 17:14
Forte Biosciences EPS Diluted (Quarterly): -0.9937 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| CEL-SCI Corp. | -0.7611 |
| AIM ImmunoTech, Inc. | -1.569 |
| IGC Pharma, Inc. | -0.0201 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Protalix Biotherapeutics, Inc. | 0.0291 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -17.68M |
| Total Expenses (Quarterly) | 17.68M |
| Enterprise Value | 248.19M |
| Earnings Yield | -18.81% |
| Normalized Earnings Yield | -18.81 |